6527 明達醫


股價漲跌幅
202220212020
明達醫-3.0%-3.0%12.0%
0050-15.78%3.82%50.48%


現價可能漲跌幅 1合理價(本益比法)一年後目標價報酬率可能漲跌幅 2合理價(ROE法)
46.3 0.65% 46.6 53.59 15.75% N/A N/A

  • 合理價(本益比法): 從 "一年後目標價" 回推得到
  • 可能漲跌幅 1: "合理價(本益比法)" 和 "現價" 的差距
  • 報酬率: 一年後可能的報酬率
  • 可能漲跌幅 2: "合理價(ROE法)" 和 "現價" 的差距
  • 推估價格僅供參考, Please Do Your Own Research

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近10年
202120202019201820172016201520142013
營業毛利率29.2932.7936.4731.0023.8226.4429.7229.0825.71
營業利益率12.2611.4317.2512.737.4910.4812.049.788.09
折舊負擔比率3.743.973.031.981.821.661.511.761.73
稅前淨利率15.1312.4816.9013.257.5011.4013.6013.5710.08
股東權益報酬率11.088.2315.6615.838.0912.4914.2413.4512.43
資產報酬率8.576.4612.0511.966.479.8811.1710.719.92
本業收入比80.7392.06101.7996.25100.0091.9488.8972.2280.49
業外獲益比19.277.94-1.793.750.008.0611.1127.7819.51
無形資產佔淨值比0.117.780.110.160.190.000.000.000.00

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q2
營業毛利率32.1834.7027.0626.8628.0130.4131.8740.4433.4130.9137.3938.6439.0432.7433.9527.81
營業利益率12.5914.8912.1810.1711.4910.2013.477.4112.7716.4015.8418.3820.5712.1018.049.69
稅前淨利率20.0321.9412.2112.2313.4711.4914.0710.4212.9913.6915.5319.1221.1012.9417.6810.57
本業收入比60.7169.05100.0080.9583.3390.0095.4571.43100.00118.18103.8595.3197.3791.67100.0092.59
業外獲益比35.7133.330.0019.0516.6710.004.5528.570.00-18.18-3.853.122.638.33-3.337.41

現金流量-近10年 (1.避開自由現金流量近3年都小於0的公司 2.營運現金流量要大於稅後淨利,除非受到應收帳款和存貨影響 3.營運現金流量不應該都是流出)
202120202019201820172016201520142013
營運現金流量(百萬)6384981015067195711
自由現金流量(百萬)-131-1018985394733021
稅後淨利(百萬)775791703450514234


現金流量-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q2
營運現金流量(百萬)-227741-6-488310-191093-610-18894
自由現金流量(百萬)-1813354-286-3177-85-23-7089-87-28015-10
稅後淨利(百萬)2224171719162261222214930252421

成長能力-近10年 (營業利益和稅後淨利成長率要大於營收成長率)
202120202019201820172016201520142013
營收(百萬)722504661606494542465398404
營業利益(百萬)8858114773757563933
稅後淨利(百萬)775791703450514234
EPS(完全稀釋)3.202.324.223.231.562.292.381.991.62
營收成長率(%)43.25-23.759.0822.67-8.8616.5616.83-1.49N/A
營業利益成長率(%)51.72-49.1248.05108.11-35.091.7943.5918.18N/A
稅後淨利成長率(%)35.09-37.3630.00105.88-32.00-1.9621.4323.53N/A
EPS成長率(%)37.93-45.0230.65107.05-31.88-3.7819.6022.84N/A

成長能力-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q218Q117Q417Q317Q2
營收(百萬)1381931801711781731546311415817033317818416725502520242
營業利益(百萬)1729221720182151526276137223025020017
稅後淨利(百萬)2224171719162261222214930252421021013
EPS(完全稀釋)0.920.990.710.730.800.670.930.250.491.030.972.271.391.191.120.970.000.960.000.61
去年同期營收成長率(%)-22.4711.5616.88171.4356.149.49-9.41-81.08-35.96-14.131.8030.590.00-26.980.005.37----
去年同期營業利益成長率(%)-15.0061.114.76240.0033.33-30.77-22.22-91.80-59.4618.18-10.00144.000.0010.000.0047.06----
去年同期稅後淨利成長率(%)15.7950.00-22.73183.3358.33-27.274.76-87.76-60.00-12.00-12.50133.330.0019.050.0061.54----
去年同期EPS成長率(%)15.0047.76-23.66192.0063.27-34.95-4.12-88.99-64.75-13.45-13.39134.020.0023.960.0059.02----
較上季營收成長率(%)-28.507.225.26-3.932.8912.34144.44-44.74-27.85-7.06-48.9587.08-3.2610.18-34.510.00-100.000.00-100.00-
較上季營業利益成長率(%)-41.3831.8229.41-15.0011.11-14.29320.00-66.67-42.31-3.70-55.7464.8668.18-26.6720.000.00-100.000.00-100.00-
較上季稅後淨利成長率(%)-8.3341.180.00-10.5318.75-27.27266.67-50.00-45.454.76-57.1463.3320.004.1714.290.00-100.000.00-100.00-
較上季EPS成長率(%)-7.0739.44-2.74-8.7519.40-27.96272.00-48.98-52.436.19-57.2763.3116.816.2515.460.00-100.000.00-100.00-

每月營收變化
年/月月增率(%)去年同期年增率(%)累計營收年增率(%)年/月月增率(%)去年同期年增率(%)累計營收年增率(%)
2022/443.4420.3-11.422019/12-36.274.719.03
2022/321.95-25.98-22.482019/116.27-15.289.32
2022/1~2-1.34-20.21-20.22019/102.5-22.412.9
2021/12-22.50.1343.072019/916.8-15.2219.12
2021/1118.2915.0148.552019/8-26.12-7.4925.52
2021/10-0.0220.1254.162019/721.0733.6131.18
2021/9-6.8817.0759.52019/62.0238.830.72
2021/832.0411.7967.632019/58.738.8629.27
2021/70.5924.2482.972019/4-34.433.4535.17
2021/6-13.5788.6896.512019/326.8842.8647.48
2021/5-5.73194.9897.92019/1~227.3150.9650.96
2021/4-11.74271.9183.22018/12-48.4424.3422.79
2021/338.8136.2655.672018/11-2.6442.6122.69
2021/1~2-11.1927.3227.312018/1011.9888.0520.24
2020/12-10.9846.14-23.72018/927.4535.0413.06
2020/1123.544.62-28.092018/86.7118.239.73
2020/10-2.56-10.0-31.672018/725.7826.588.4
2020/9-11.08-5.32-34.152018/6-19.9751.455.5
2020/846.7524.37-37.782018/53.3211.00.05
2020/752.76-37.38-45.32018/4-9.45-13.06-2.71
2020/635.11-50.37-46.842018/357.0647.291.99
2020/518.85-62.52-46.162018/1~2-8.39-17.14-17.13
2020/4-43.93-65.71-42.362017/12-40.74188.14-8.92
2020/3-24.19-59.9-36.02017/1128.3836.02-12.79
2020/1~2-13.39-19.01-19.012017/10-19.58-29.75-16.47

稅前淨利較去年同期
2022Q1(百萬)2021Q1(百萬)YoY(%)
28.024.016.666
2021Q4(百萬)2020Q4(百萬)YoY(%)
42.020.0110.00
2021Q3(百萬)2020Q3(百萬)YoY(%)
22.022.00.0

EPS較上季
2022Q1(元)2021Q4(元)比率
0.920.99-0.070

應收帳周轉率和存貨周轉率-近10年
202120202019201820172016201520142013
應收帳款周轉率6.965.7110.2912.9217.8419.2010.598.9512.18
存貨周轉率2.882.142.612.762.542.722.943.374.00

應收帳周轉率和存貨周轉率-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q2
應收帳款周轉率1.341.751.611.411.581.792.091.151.651.592.015.182.842.752.585.38
存貨周轉率0.420.610.590.600.730.760.620.230.490.640.621.140.610.740.711.18

償債能力-近10年
202120202019201820172016201520142013
負債比0.230.240.220.270.220.190.230.200.21
金融負債(百萬)000000000
營收淨額(百萬)722504661606494542465398404
利息保障倍數93.9947.8575.050.000.000.000.000.000.00
長期銀行借款占稅後淨利比0.000.000.000.000.000.000.000.000.00

成本指標-近10年
202120202019201820172016201520142013
營收淨額(百萬)722504661606494542465398404
推銷費用(百萬)2722252420111077
管理費用(百萬)474460482736342319
研發費(百萬)494143393439394645
推銷費用率(%)3.744.373.783.964.052.032.151.761.73
管理費用率(%)6.518.739.087.925.476.647.315.784.70
研發費用率(%)6.798.136.516.446.887.208.3911.5611.14

成本指標-近20季
22Q121Q421Q321Q221Q120Q420Q320Q220Q119Q419Q319Q219Q118Q418Q318Q2
營收淨額(百萬)13819318017117817315463114158170333178184167255
推銷費用(百萬)786666556471368610
管理費用(百萬)111411111116118911173216181119
研發費(百萬)9161011121312898132211121017
推銷費用率(%)5.074.153.333.513.373.473.257.945.262.534.123.903.374.353.593.92
管理費用率(%)7.977.256.116.436.189.257.1412.707.896.9610.009.618.999.786.597.45
研發費用率(%)6.528.295.566.436.747.517.7912.707.895.067.656.616.186.525.996.67

財務健檢燈號
公司上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
6527-明達醫OXXOOOOXXX
3年2.43億94.15%22.05%0.0%71.60%90百萬12.08%


明達醫熱門網頁

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。